Skip to content
Colorectal Cancer Clinical Trials

North Carolina

Colorectal cancer clinical trials in North Carolina

72 colorectal cancer studies are recruiting participants at sites in 39 cities across North Carolina as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 385-9581
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every North Carolina city with a recruiting study

Durham (38), Chapel Hill (13), Charlotte (9), Huntersville (8), Winston-Salem (6), Goldsboro (5), Raleigh (5), Clinton (4), Concord (4), Gastonia (4), Greenville (4), Jacksonville (4), Pinehurst (4), Cary (3), Greensboro (3), Hendersonville (3), Asheboro (2), Asheville (2), Burlington (2), Clemmons (2), Hillsborough (2), Lincolnton (2), Monroe (2), Reidsville (2), Wilson (2), Albemarle (1), Clyde (1), Fayetteville (1), Forest City (1), Garner (1), High Point (1), Kernersville (1), Matthews (1), Morrisville (1), Mount Airy (1), Salisbury (1), Shelby (1), Weaverville (1), Wilkesboro (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in North Carolina

Basic details from each study's public record (the 12 most recently updated of 72). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Durham · Raleigh · Winston-Salem
    Registry record
    NCT05863195 · updated
  2. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Recruiting in
    Durham
    Registry record
    NCT07488676 · updated
  3. A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pliant Therapeutics, Inc.
    Recruiting in
    Wilson
    Registry record
    NCT06270706 · updated
  4. Shield Post-Approval Study Protocol

    • Observational
    • Ages 45 to 81
    • All sexes
    Sponsor
    Guardant Health, Inc.
    Recruiting in
    Cary · Chapel Hill · Hillsborough
    Registry record
    NCT06880055 · updated
  5. A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Raleigh
    Registry record
    NCT06997497 · updated
  6. A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Recruiting in
    Chapel Hill
    Registry record
    NCT07659795 · updated
  7. The Vanguard Study: Testing a New Way to Screen for Cancer

    • No phase
    • Ages 45 to 75
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Chapel Hill · Durham
    Registry record
    NCT06995898 · updated
  8. Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    SWOG Cancer Research Network
    Recruiting in
    Asheboro · Burlington · Greensboro · and 2 more U.S. locations
    Registry record
    NCT07018869 · updated
  9. Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

    • Observational
    • Ages 60 and older
    • All sexes
    Sponsor
    Wake Forest University Health Sciences
    Recruiting in
    Charlotte · Clemmons · Concord · and 3 more U.S. locations
    Registry record
    NCT03998202 · updated
  10. Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Summit Therapeutics
    Recruiting in
    Pinehurst
    Registry record
    NCT07228832 · updated
  11. Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

    • No phase
    • Ages 45 to 70
    • All sexes
    Sponsor
    NRG Oncology
    Recruiting in
    Clinton · Durham · Goldsboro · and 1 more U.S. location
    Registry record
    NCT05080673 · updated
  12. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    NRG Oncology
    Recruiting in
    Cary · Chapel Hill · Charlotte · and 14 more U.S. locations
    Registry record
    NCT05174169 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in North Carolina on ClinicalTrials.gov.

Ask about studies in North Carolina

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call